Day 2 (2024)
The American Migraine Foundation (AMF) is a non-profit organization dedicated to the advancement of research and awareness surrounding migraine, a disabling condition that impacts more than 37 million men, women and children in the United States. The AMF was founded in 2010 to provide global access to information and resources for individuals with migraine as well as their family and friends.
At AbbVie, we are committed to empowering people living with migraine disease. We advance science that enables health care providers to care for people impacted across the spectrum of migraine. Through education and partnerships with the migraine community, we strive to help those with migraine navigate barriers to care, access effective treatments and reduce the impact of migraine on their lives. To learn more, visit AbbVie.com.
Noticing new symptoms? Struggling with Chronic Migraine? Need hope? Try these Learning Tracks to more to get the most out of your Summit experience.
Today's Interviews
Migraine Biochemistry: CGRP & Beyond
Peter Goadsby, MD, PhD, FRS
Professor of Neurology and Neurologist
King's College London
How Much Is Too Much Excedrin Migraine?
Paul G. Mathew, MD, DNBPAS, FAAN, FAHS
Assistant Professor of Neurology
Harvard Medical School
The Gut Factor: Exploring the Role of Digestive Health in Migraine
Vince Martin, MD, AQH
Director
Headache & Facial Pain Center at the University of Cincinnati Gardner Neuroscience Institute
Menopause, Perimenopause & Migraine
Christine Lay, MD, FAHS
Professor of Neurology, Deborah Ivy Christiani Brill Chair
University of Toronto
Purchase full access to the entire 2024 Summit to unlock:
- All expert interviews with separate audio (MP3) files & transcripts
- 30 extended, uncut interview editions with hours more expert footage
- Lifetime on-demand access with no annual fee to 2024 Summit
- Interview Summaries
- Treatment Directory & Guidelines
- And much more!
